deoxynivalenol has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Domińska, K; Habrowska-Górczyńska, DE; Kowalska, K; Piastowska-Ciesielska, AW; Sakowicz, A; Urbanek, KA | 2 |
| Domińska, K; Habrowska-Górczyńska, DE; Kowalska, K; Kozieł, MJ; Piastowska-Ciesielska, AW; Urbanek, KA | 1 |
3 other study(ies) available for deoxynivalenol and Prostatic Neoplasms
| Article | Year |
|---|---|
In Vitro Analysis of Deoxynivalenol Influence on Steroidogenesis in Prostate.
Topics: Cell Line; Cell Line, Tumor; Dehydroepiandrosterone; Estradiol; Gene Expression Regulation; Humans; Male; Progesterone; Prostate; Prostatic Neoplasms; Steroids; Testosterone; Trichothecenes | 2021 |
Effect of the mycotoxin deoxynivalenol in combinational therapy with TRAIL on prostate cancer cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Humans; Ligands; Male; Mice; Mycotoxins; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2023 |
Deoxynivalenol Modulates the Viability, ROS Production and Apoptosis in Prostate Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Male; Prostatic Neoplasms; Reactive Oxygen Species; Trichothecenes | 2019 |